Polar Capital Holdings PLC Cytokinetics Inc Transaction History

Polar Capital Holdings PLC

$16.3 Billion
Q4 2024

A detailed history of Polar Capital Holdings PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Polar Capital Holdings PLC holds 2,196,721 shares of CYTK stock, worth $88.8 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

2,196,721

Previous 2,337,847 6.04%

Holding current value

$88.8 Million

Previous $123 Million 16.29%

% of portfolio

0.64%

Previous 0.76%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$46.36 - $58.62 $6.54 Million - $8.27 Million	-141,126 Reduced 6.04%	2,196,721 $103 Million
Q3 2024 Nov 14, 2024	SELL	$51.22 - $60.16 $5.98 Million - $7.03 Million	-116,818 Reduced 4.76%	2,337,847 $123 Million
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $40.6 Million - $63.7 Million	849,089 Added 52.88%	2,454,665 $133 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $12 Million - $20.4 Million	188,522 Added 13.3%	1,605,576 $113 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $33.3 Million - $103 Million	-1,237,391 Reduced 46.62%	1,417,054 $118 Million
Q2 2023 Dec 13, 2023	BUY	$32.62 - $40.75 $1.39 Million - $1.74 Million	42,753 Added 1.64%	2,654,445 $86.6 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $1.39 Million - $1.74 Million	42,753 Added 1.64%	2,654,445 $86.6 Million
Q1 2023 Dec 13, 2023	SELL	$33.36 - $45.71 $1.43 Million - $1.95 Million	-42,753 Reduced 1.61%	2,611,692 $91.9 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $3.77 Million - $5.17 Million	-113,085 Reduced 4.15%	2,611,692 $91.9 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $1.9 Million - $2.72 Million	53,129 Added 1.99%	2,724,777 $125 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $13.7 Million - $19.4 Million	-355,000 Reduced 11.73%	2,671,648 $129 Million
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $5.25 Million - $7.57 Million	-154,652 Reduced 4.86%	3,026,648 $119 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $14.6 Million - $22.6 Million	-490,669 Reduced 13.36%	3,181,300 $117 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $22.6 Million - $30.5 Million	657,087 Added 21.79%	3,671,969 $167 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $10.9 Million - $20.9 Million	585,782 Added 24.12%	3,014,882 $108 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $4.8 Million - $6.55 Million	-242,784 Reduced 9.09%	2,429,100 $48.1 Million
Q1 2021 May 17, 2021	SELL	$18.57 - $25.68 $11.1 Million - $15.4 Million	-600,000 Reduced 18.34%	2,671,884 $62.1 Million
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $49.9 Million - $93.6 Million	3,271,884 New	3,271,884 $68 Million

Others Institutions Holding CYTK

# of Institutions

400

Shares Held

115M

Call Options Held

3.46M

Put Options Held

1.86M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.81B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account

Polar Capital Holdings PLC Cytokinetics Inc Transaction History